ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

Transfusion - Tập 46 Số 10 - Trang 1836-1844 - 2006
P. Vincent Jenkins1, James S. O’Donnell1
1From the National Center for Hereditary Coagulation Disorders and Department of Haematology, Institute of Molecular Medicine, St. James’s Hospital and Trinity College, Dublin, Ireland.

Tóm tắt

For many years, an association between ABO histo‐blood group and risk of thrombosis has been recognized. Blood group non‐O (A, B, and AB) individuals have consistently been found to demonstrate increased incidence of both arterial and venous thrombotic disease, compared to group O individuals. This increased risk is attributable to the fact that ABO blood group influences plasma levels of a coagulation glycoprotein named von Willebrand factor (VWF). VWF levels are 25 percent higher in non‐O compared to group O individuals. The mechanism by which ABO group determines plasma VWF levels has not been determined. ABO(H) carbohydrate antigenic determinants, however, are expressed on the N‐linked glycan chains of circulating plasma VWF. This review will focus on the carbohydrate structures of VWF and recent studies suggesting that subtle variations in these structures (particularly differences in ABO blood group antigen expression) may have clinically significant effects on VWF proteolysis and clearance.

Từ khóa


Tài liệu tham khảo

10.1053/tmrv.2000.16228

Yamamoto F, 2000, Molecular genetics of ABO, Vox Sang, 78, 91

10.1016/S0950-3536(05)80155-6

Oriol R, 1992, Genetic regulation of the expression of ABH and Lewis antigens in tissues, APMIS Suppl, 27, 28

10.1023/A:1018581503164

10.1136/bmj.1.4814.799

10.1136/gut.6.2.134

10.1046/j.1365-3148.2001.00315.x

10.1016/S0140-6736(95)90166-3

10.1182/blood.V69.6.1691.1691

10.1146/annurev.biochem.67.1.395

10.1083/jcb.99.6.2123

10.1073/pnas.92.7.2455

10.1055/s-0037-1615018

Girma JP, 1987, Structure‐function relationship of human von Willebrand factor, Blood, 70, 605, 10.1182/blood.V70.3.605.605

10.1182/blood.V57.6.1140.1140

10.1055/s-0037-1614927

10.1161/01.ATV.13.3.398

10.1055/s-0038-1650400

10.1016/S0021-9258(19)81299-1

Denis C, 1993, Solid‐phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor, Blood, 82, 3622, 10.1182/blood.V82.12.3622.3622

10.1016/S0021-9258(18)47430-3

10.1055/s-0037-1615885

10.1038/35097008

10.1074/jbc.C100515200

10.1097/00005792-199701000-00001

10.1097/00062752-200209000-00001

10.1074/jbc.M310436200

10.1097/00001721-199806000-00009

Stoddart JH, 1996, Clearance of normal and type 2A von Willebrand factor in the rat, Blood, 88, 1692, 10.1182/blood.V88.5.1692.1692

10.1182/blood.V90.9.3555

10.1146/annurev.bi.51.070182.002531

10.1046/j.1365-2141.1997.4823285.x

10.1046/j.1538-7836.2003.00359.x

Matsui T, 1992, Structures of the asparagine‐linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures, J Biol Chem, 267, 8723, 10.1016/S0021-9258(19)50338-6

10.1182/blood.V82.2.663.663

Matsui T, 1999, ABO blood group antigens on human plasma von Willebrand factor after ABO‐mismatched bone marrow transplantation, Blood, 94, 2895, 10.1182/blood.V94.8.2895.420a03_2895_2900

10.1159/000054087

10.1055/s-0037-1613123

Sodetz JM, 1979, Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor, J Biol Chem, 254, 10754, 10.1016/S0021-9258(19)86586-9

10.1007/BF01047846

10.1111/j.1365-2141.1999.01317.x

Orstavik KH, 1985, Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level, Am J Hum Genet, 37, 89

McCallum CJ, 1983, Factor VIII levels and blood group antigens, Thromb Haemost, 50, 757, 10.1055/s-0038-1665305

Mohanty D, 1984, Major blood group antigens—a determinant of factor VIII levels in blood?, Thromb Haemost, 51, 414, 10.1055/s-0038-1661121

10.1111/j.1423-0410.1995.tb02579.x

10.1161/01.ATV.20.8.2024

10.1161/hq0202.103997

10.1046/j.1538-7836.2003.00367.x

10.1056/NEJM197112092852404

Orstavik KH, 1989, Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor, Blood, 73, 990, 10.1182/blood.V73.4.990.990

10.1046/j.1365-2141.2002.03270.x

10.1111/j.1365-2141.2004.05249.x

O’Donnell J, 2002, The relationship between plasma concentration of alpha2‐macroglobulin and ABO blood group, Thromb Haemost, 88, 167, 10.1055/s-0037-1613176

10.1046/j.1365-2141.2003.04366.x

10.1016/0049-3848(92)90097-T

10.1016/S0021-9258(19)63384-3

10.1046/j.1538-7836.2003.00007.x

10.1182/blood-2005-02-0792

10.1021/bi00359a015

Jenkins PV, 1998, Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand’s disease, Blood, 91, 2032, 10.1182/blood.V91.6.2032

10.1093/glycob/cwh008

10.1182/blood-2004-01-0376

10.1073/pnas.142005099

10.1016/S0092-8674(00)80964-2

10.1055/s-0037-1613759

10.1046/j.1365-2141.2000.02113.x

10.1172/JCI116112

10.1172/JCI111628

Kao KJ, 1980, Factor VIII/von Willebrand protein: modification of its carbohydrate causes reduced binding to platelets, J Biol Chem, 255, 10134, 10.1016/S0021-9258(19)70438-4

10.1182/blood.V72.5.1790.1790

10.1097/00001721-200501000-00012

10.1046/j.1537-2995.1998.381098440863.x

Feizi T, 1982, Blood group antigens and gastric cancer, Med Biol, 60, 7

Thông tin
Thông tin xuất bản

Transfusion

Tập 46 Số 10

1836-1844

Thông tin tác giả